Navigation Links
Smart 2940 Plus

ProductsSmart 2940 Plus
Company DEKA Research & Development Corp.
Item Smart 2940 Plus
Features Inquire
Description The Erbium (Er:YAG) laser is the ideal instrument for safe, repeatable tissular ablation. Thanks to Smart 2940 Plus, the majority of surface lesions can be treated, including wrinkles and a wide range of scar tissue, with a minimum of heat damage and in most cases with the elimination of anaesthetics, risks and adverse side effects. Smart 2940 Plus incorporates sophisticated pulse-length controls for enhancing the ablative effect and heat action.
Info DEKA Research & Development Corp.
Customer Service:

Related medicine products :

1. Smart Refractor RT-5100
2. OSV II Smart Valve
3. SmartPLUG™
4. WaveMap™ & SmartWire™ Pressure System
5. Smartmap Pressure Instrument
6. 3.5v Streak Retinoscope Set with Lithium-Ion (Smart) Handle and Hard Case
7. SmartPLUG
8. SmartScrew ACL
9. SmartVac Smoke Evacuation System
10. Smart OR™
11. Smartepil II Long Pulse Nd:YAG Laser
TAG: Smart Plus
Integrated electronics, three-chip CCD camera with PAL and NTSC output at 750 lines, RGB-video. 44mm x 49mm x 75mm, 180 grams.
Large image and wide-angle design.
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy.
PDA application listing specific ICD-9 coding listed in new Medicare National Coverage Determinations.
Medicine Products:
(Date:11/21/2008)...tCall/ -- Today, prescription drugs are the first ...cent of patients suffering chronic conditions. Th...ndition account for 96 percent of all prescription.... A proprietary new pharmacy model developed over...: MHS ) significantly reduces critical gaps in c...
(Date:11/21/2008)... survey, 33 physicians credentialed to practice at...ospital of Dallas were honored by Texas Monthly ..., , Each year, the publishers of Texas Mont...vey more than 38,000 medical professionals across ...care, which doctor would you choose?" Key Profess...
(Date:11/21/2008)...and smoking cessation less likely among persons wi....D.) In a study of smokers with attention deficit...levated hyperactivity and impulsivity, with or wit...weeks than those with inattention symptoms alone o... now available online in Nicotine and Tobacco Res...
(Date:11/21/2008)...ions in computerized brain,training may help peop...uller,lives, said Jeff Zimman, Chairman of Posit ... the annual Technology Innovators Conference in Wa... Center for Technology Innovation to,promote inno... Zimman said cognitive training programs can assi...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2Health News:New Applications for Cognitive Training 2
...Frank Nweke has said in a statement that a pathoge...s//, and one among them is Nigeria’s southern most...turpo in the central state of Benue and Port Harco...med to have the bird-flu virus. According to Frank...
...the number of deaths linked to Multidrug Resistant... doubled in the past four years//. Patients are re... On such case is that of a widow Freda Geldard, 6...cquiring MRSA. She says that she will travel to Br...
...ostate cancer patients face a delay of two months ...r is one of the most common cancers in Scotland. B... struggling to hit their target. Andy Kerr, healt...rities to reduce the waiting times to make it easi...
...the rise and is an important cause of death in the...e among the Filipinos is shooting up every year. A...or life or a kidney transplant for survival. About... disease. Hence it is very essential to find a cur...
Other Medicine News:Health News:Kidney diseases and their complications, an alarming scenario in the Philippines 2
(Date:11/20/2008)...ULTS OF FIRST PHASE III TRIAL SHOW SIGNIFICANT, ...IN DAILY FUNCTION, IN, ...nd BRUSSELS, Belgium, Nov. 20 /PRNewswire-FirstCal...) and UCB (Euronext Brussels: UCB),announced toda...irst of two,Phase III pivotal clinical trials of ...
(Date:11/20/2008)... Bionovo, Inc.,(Nasdaq: ...s from the Phase 1B,clinical trial of their lead ...cer, BZL101, at the Society for Integrative Oncolo...eorgia. The Company,s oral presentation was selec...ed as a part of the Best of the,SIO Session on No...
(Date:11/20/2008)...e/ -- Clinical data from a prospective,registry p...ium shows DVT,treatment with the Trellis(R) Perip... (Santa Clara, CA) successfully breaks up the bloo... This technique, called isolated pharmacomecha...kly and safely than current catheter-directed thro...
(Date:11/19/2008)...wswire/ -- Posit Science Corporation,researcher, ...Neuroscience,Annual Conference in Washington, DC ...benefit Baby Boomers. The computerized brain plas...tive exercises that target auditory and,language ...ralized,improvements in cognition by improving sp...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Complementary Excerpt Available from Best Practices 3A Rewarding and Recognizing Top Performing Sales People 17231 1Complementary Excerpt Available from Best Practices 3A Rewarding and Recognizing Top Performing Sales People 17231 2Statement 3A Congress Should Include the Physician Self Referral Provision in the Farm Bill for Patients and Communities 17229 1Statement 3A Congress Should Include the Physician Self Referral Provision in the Farm Bill for Patients and Communities 17229 2Yongye Biotechnology Completes Reverse Merger and Completes 2410 0 Million Private Financing 4707 1Yongye Biotechnology Completes Reverse Merger and Completes 2410 0 Million Private Financing 4707 2Yongye Biotechnology Completes Reverse Merger and Completes 2410 0 Million Private Financing 4707 3High anxiety 3F 17227 1
...Therapeutics,Inc., a specialty pharmaceutical com...ory and infectious diseases, today announced,the c...ascana,– a topical formulation designed to t...primary end point and demonstrated statistical,sig...patient,population. Typically, a probability valu...
...ss and upcoming,milestones on its insulin program ... SemBioSys,Genetics Inc. , a biotechnology company...r metabolic and cardiovascular disease,today anno...elopment of plant-derived recombinant human insuli...Scientific Sessions of the,American Diabetes Assoc...
Other Medicine Technology:MediQuest Concludes Confirmatory Phase III Study of Raynaud’s,Therapy 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 4